FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019427269> ?p ?o ?g. }

• W2019427269 endingPage "222" @default.
• W2019427269 startingPage "215" @default.
• W2019427269 abstract "The role of interleukin-6 (IL-6) in autoimmunity attracts attention because of the clinical usage of monoclonal antibodies to IL-6 receptor (IL-6R), designed to block IL-6 pathways. In autoimmune liver disease, activation of the hepatocyte IL-6/STAT3 (signal transducer and activator of transcription 3) pathway is associated with modulating pathology in acute liver failure, in liver regeneration, and in the murine model of concanavalin A–induced liver inflammation. We have reported that mice expressing a dominant negative form of transforming growth factor β receptor II (dnTGFβRII) under control of the CD4 promoter develop both colitis and autoimmune cholangitis with elevated serum levels of IL-6. Based on this observation, we generated IL-6–deficient mice on a dnTGF-βRII background (dnTGFβRII IL-6−/−) and examined for the presence of antimitochondrial antibodies, levels of cytokines, histopathology, and immunohistochemistry of liver and colon tissues. As expected, based on reports of the use of anti–IL-6R in inflammatory bowel disease, dnTGFβRII IL-6−/− mice manifest a dramatic improvement in their inflammatory bowel disease, including reduced diarrhea and significant reduction in intestinal lymphocytic infiltrates. Importantly, however, autoimmune cholangitis in dnTGFβRII IL-6−/− mice was significantly exacerbated, including elevated inflammatory cytokines, increased numbers of activated T cells, and worsening hepatic pathology. Conclusion: The data from these observations emphasize that there are distinct mechanisms involved in inducing pathology in inflammatory bowel disease compared to autoimmune cholangitis. These data also suggest that patients with inflammatory bowel disease may not be the best candidates for treatment with anti–IL-6R if they have accompanying autoimmune liver disease and emphasize caution for therapeutic use of anti–IL-6R antibody. HEPATOLOGY 2010" @default.
• W2019427269 created "2016-06-24" @default.
• W2019427269 creator A5013188999 @default.
• W2019427269 creator A5019715351 @default.
• W2019427269 creator A5026873284 @default.
• W2019427269 creator A5029678899 @default.
• W2019427269 creator A5035953102 @default.
• W2019427269 creator A5039708803 @default.
• W2019427269 creator A5041092935 @default.
• W2019427269 creator A5064443404 @default.
• W2019427269 creator A5066462726 @default.
• W2019427269 creator A5073313443 @default.
• W2019427269 creator A5090529676 @default.
• W2019427269 date "2010-03-15" @default.
• W2019427269 modified "2023-10-16" @default.
• W2019427269 title "Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor β receptor II improves colitis but exacerbates autoimmune cholangitis" @default.
• W2019427269 cites W1502931635 @default.
• W2019427269 cites W1519262347 @default.
• W2019427269 cites W1602943807 @default.
• W2019427269 cites W1650215555 @default.
• W2019427269 cites W1776476655 @default.
• W2019427269 cites W1788537342 @default.
• W2019427269 cites W1856703017 @default.
• W2019427269 cites W1971013426 @default.
• W2019427269 cites W1976248437 @default.
• W2019427269 cites W1977492688 @default.
• W2019427269 cites W1982875532 @default.
• W2019427269 cites W1984162039 @default.
• W2019427269 cites W1993965822 @default.
• W2019427269 cites W2002076761 @default.
• W2019427269 cites W2007557866 @default.
• W2019427269 cites W2008535165 @default.
• W2019427269 cites W2010798754 @default.
• W2019427269 cites W2018498519 @default.
• W2019427269 cites W2019481852 @default.
• W2019427269 cites W2024255214 @default.
• W2019427269 cites W2024447443 @default.
• W2019427269 cites W2026691713 @default.
• W2019427269 cites W2029174110 @default.
• W2019427269 cites W2033286476 @default.
• W2019427269 cites W2034368893 @default.
• W2019427269 cites W2035505806 @default.
• W2019427269 cites W2036966708 @default.
• W2019427269 cites W2036988498 @default.
• W2019427269 cites W2039845199 @default.
• W2019427269 cites W2041767278 @default.
• W2019427269 cites W2044608575 @default.
• W2019427269 cites W2047283939 @default.
• W2019427269 cites W2053867211 @default.
• W2019427269 cites W2055253557 @default.
• W2019427269 cites W2057018521 @default.
• W2019427269 cites W2063583362 @default.
• W2019427269 cites W2069874049 @default.
• W2019427269 cites W2072150914 @default.
• W2019427269 cites W2086002849 @default.
• W2019427269 cites W2090425412 @default.
• W2019427269 cites W2092151512 @default.
• W2019427269 cites W2101217954 @default.
• W2019427269 cites W2111034338 @default.
• W2019427269 cites W2117521006 @default.
• W2019427269 cites W2119790306 @default.
• W2019427269 cites W2132286068 @default.
• W2019427269 cites W2134341159 @default.
• W2019427269 cites W2135070276 @default.
• W2019427269 cites W2135575955 @default.
• W2019427269 cites W2138314644 @default.
• W2019427269 cites W2150952126 @default.
• W2019427269 cites W2167512484 @default.
• W2019427269 cites W2168822788 @default.
• W2019427269 cites W2474873081 @default.
• W2019427269 cites W4292540530 @default.
• W2019427269 doi "https://doi.org/10.1002/hep.23664" @default.
• W2019427269 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2936774" @default.
• W2019427269 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20578264" @default.
• W2019427269 hasPublicationYear "2010" @default.
• W2019427269 type Work @default.
• W2019427269 sameAs 2019427269 @default.
• W2019427269 citedByCount "27" @default.
• W2019427269 countsByYear W20194272692012 @default.
• W2019427269 countsByYear W20194272692013 @default.
• W2019427269 countsByYear W20194272692014 @default.
• W2019427269 countsByYear W20194272692015 @default.
• W2019427269 countsByYear W20194272692016 @default.
• W2019427269 countsByYear W20194272692017 @default.
• W2019427269 countsByYear W20194272692018 @default.
• W2019427269 countsByYear W20194272692019 @default.
• W2019427269 countsByYear W20194272692020 @default.
• W2019427269 crossrefType "journal-article" @default.
• W2019427269 hasAuthorship W2019427269A5013188999 @default.
• W2019427269 hasAuthorship W2019427269A5019715351 @default.
• W2019427269 hasAuthorship W2019427269A5026873284 @default.
• W2019427269 hasAuthorship W2019427269A5029678899 @default.
• W2019427269 hasAuthorship W2019427269A5035953102 @default.
• W2019427269 hasAuthorship W2019427269A5039708803 @default.
• W2019427269 hasAuthorship W2019427269A5041092935 @default.
• W2019427269 hasAuthorship W2019427269A5064443404 @default.
• W2019427269 hasAuthorship W2019427269A5066462726 @default.
• W2019427269 hasAuthorship W2019427269A5073313443 @default.

• next